Hepatitis e vaccine debuts

Nature

Volumn 491, Issue 7422, 2012, Pages 21-22

  Park, Soo Bin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HECOLIN; HEPATITIS E VACCINE; UNCLASSIFIED DRUG;

ACUTE LIVER FAILURE; BACTERIAL STRAIN; DRUG COST; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; EPIDEMIC; ESCHERICHIA COLI; FOOD AND DRUG ADMINISTRATION; HEPATITIS E; HUMAN; INFECTION PREVENTION; MORTALITY; NOTE; PRIORITY JOURNAL; SANITATION; WART VIRUS; WORLD HEALTH ORGANIZATION;

AFRICA; BIOTECHNOLOGY; CHINA; DRUG INDUSTRY; FEMALE; HEPATITIS E; HUMANS; PREGNANCY; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; VACCINES, SYNTHETIC; VIRAL HEPATITIS VACCINES;

EID: 84868315547     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/491021a     Document Type: Note

References (4)

1. Zhuang, H., Cao, X. Y., Liu, C. B. & Wang, G. M. Gastroenterol. Jpn. 26, 135-138 (1991).
2. Zhu, F.-C. et al. Lancet 376, 895-902 (2010).
3. Shrestha, M. P. et al. N. Engl. J. Med. 356, 895-903 (2007).
4. Teshale, E. H. et al. Emerg. Infect. Dis. 16, 126-129 (2010).